![](/img/cover-not-exists.png)
A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer
Sato, Yasushi, Ohnuma, Hiroyuki, Hirakawa, Masahiro, Takahashi, Minoru, Osuga, Takahiro, Okagawa, Yutaka, Murase, Kazuyuki, Takada, Kohichi, Kawano, Yutaka, Iyama, Satoshi, Hayashi, Tsuyoshi, Sato, TsVolume:
75
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2672-9
Date:
March, 2015
File:
PDF, 202 KB
english, 2015